Submitted by Anonymous (not verified) on 26 November 2024 - 16:22
Human medicines European public assessment report (EPAR): Cervarix, human papillomavirus vaccine [types 16, 18] (recombinant, adjuvanted, adsorbed), Date of authorisation: 20/09/2007, Revision: 42, Status: Authorised
Source: